Omeros | OMER - Przychody Ze Sprzedaży





Obroty Zmiana Data
Adma Biologics USD 114.5M 24.66M 2026-03
Alnylam Pharmaceuticals USD 1.17B 70M 2026-03
BioMarin Pharmaceutical USD 766M 109M 2026-03
Cytokinetics USD 19.35M 1.59M 2026-03
Gilead Sciences USD 7B 930M 2026-03
Heron Therapeutics USD 40.59M 2.38M 2025-12
Insmed USD 305.96M 42.16M 2026-03
Knight Therapeutics CAD 133.11M 11.56M 2025-12
MacroGenics USD 20.8M 20.43M 2026-03
Pacira USD 177M 19.87M 2026-03
Pfizer USD 14.5B 3.08B 2026-03
Rockwell Medical USD 25.83M 3.15M 2024-06
Sangamo BioSciences USD 356K 125K 2024-06
Sarepta Therapeutics USD 730.8M 287.9M 2026-03
United Therapeutics USD 781.5M 8.7M 2026-03
Vertex Pharmaceuticals USD 2.99B 200M 2026-03
Xoma USD 25K 5M 2024-09